HALIE HALL: Open Payments
NPI 1891406138 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,715 in 130 payments from 33 companies in 2025. Trend: 2023 $226 · 2024 $1,517 · 2025 $2,715
Food & beverage: $2,520Education: $195
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $397 |
| Merck Sharp & Dohme LLC | 14 | $268 |
| ABBVIE INC. | 16 | $262 |
| Daiichi Sankyo Inc. | 7 | $239 |
| AstraZeneca Pharmaceuticals LP | 10 | $201 |
| PFIZER INC. | 12 | $186 |
| Novartis Pharmaceuticals Corporation | 8 | $154 |
| GlaxoSmithKline, LLC. | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $92 |
| Incyte Corporation | 4 | $78 |
Products named: ENHERTU, KEYTRUDA, DARZALEX, ERLEADA, ELAHERE, KISQALI, VENCLEXTA, XYNTHA.
Industry payments across MO — which companies pay providers there.
